Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
Ooki A, Morita S, Tsuji A, Iwamoto S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Suto T, Hashiguchi Y, Yabuno T, Ando M, Sakamoto J, Yamaguchi K.
Ooki A, et al. Among authors: sakamoto j.
BMC Cancer. 2022 Jun 28;22(1):711. doi: 10.1186/s12885-022-09811-x.
BMC Cancer. 2022.
PMID: 35765021
Free PMC article.
Clinical Trial.